Morsela - Millennium Pharmacon Ma Marketing

All Insiders . Indonesia . 
Stock . Millennium Pharmacon International . Stakeholders . Insider . Morsela
SDPC Stock  IDR 158.00  15.00  8.67%   

Insider

Morsela is Ma Marketing of Millennium Pharmacon International
Phone62 21 270 85961
Webhttps://www.mpi-indonesia.co.id

Millennium Pharmacon Management Efficiency

The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.
Millennium Pharmacon International has accumulated 1.8 B in total debt with debt to equity ratio (D/E) of 257.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Millennium Pharmacon has a current ratio of 1.13, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Millennium Pharmacon until it has trouble settling it off, either with new capital or with free cash flow. So, Millennium Pharmacon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Millennium Pharmacon sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Millennium to invest in growth at high rates of return. When we think about Millennium Pharmacon's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Sahat SihombingAstra Graphia Tbk
N/A
Yasumasa ZaizenHexindo Adiperkasa Tbk
N/A
Melinda PudjoAstra Graphia Tbk
41
Emylia MurniasihLautan Luas Tbk
N/A
YoshendriHexindo Adiperkasa Tbk
54
LucyCitra Marga Nusaphala
N/A
Riki SusantoAstra Graphia Tbk
N/A
Benny SCitra Marga Nusaphala
N/A
Mario PangestuLautan Luas Tbk
N/A
Tje JapLautan Luas Tbk
N/A
Muhammad ThamrinHexindo Adiperkasa Tbk
46
Kuat SantosoAstra Graphia Tbk
N/A
Budi SantosoAstra Graphia Tbk
N/A
Dwi SwasonoHexindo Adiperkasa Tbk
52
ZahirmanHexindo Adiperkasa Tbk
N/A
EnizolaCitra Marga Nusaphala
N/A
Hiroshi MotegiHexindo Adiperkasa Tbk
N/A
T CahyadiCitra Marga Nusaphala
N/A
Rudy LubisCitra Marga Nusaphala
N/A
Ridwan AdipoetraLautan Luas Tbk
N/A
Engineer GultomHexindo Adiperkasa Tbk
61
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people. Millennium Pharmacon International (SDPC) is traded on Jakarta Exchange in Indonesia and employs 1,089 people.

Management Performance

Return On Equity0.0938
Return On Asset0.0342

Millennium Pharmacon Leadership Team

Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ahmad Bakar, Pres Director
Morsela, Ma Marketing
Mohamad Hassan, F Director
Aris, Chairman Audit
Puji Hartono, Head Unit
Dedi Martadiredja, Sr Sales
Yungkis Sucandra, Head Unit
Olga Bolang, Co Sec
Yuni Arrivani, Deputy Legal

Millennium Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0938
Return On Asset0.0342
Profit Margin0.01 %
Operating Margin0.02 %
Current Valuation828.27 B
Shares Outstanding1.27 B
Shares Owned By Insiders87.94 %
Shares Owned By Institutions3.35 %
Price To Earning9.31 X
Price To Book1.16 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Millennium Stock

Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY